Zura Bio Stock (NASDAQ:ZURA)
Previous Close
$1.07
52W Range
$0.97 - $6.03
50D Avg
$1.27
200D Avg
$2.60
Market Cap
$64.97M
Avg Vol (3M)
$371.58K
Beta
0.04
Div Yield
-
ZURA Company Profile
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.